SHPA Clinical Seminars: expand your knowledge – develop your skills – build your confidence : 30/04/2012 :

With tutors who are experienced clinicians and experts in their field, SHPA Clinical Seminars offer you up-to-date information that will improve your knowledge and skills and help you in your day-to-day practice.

Attending an SHPA Clinical Seminar is a great addition to your resumé; it can equip you for the next step in your career.

What do you get?

You need to log in to read the rest of this article. Click here for details

Priceline pushes $30 in store flu vaccine : 30/04/2012 :

As part of the promotional strategy for its $30 in store flu vaccine, the Priceline pharmacy group is highlighting the popularity of instore vaccination overseas.

According to Priceline, in the United States, pharmacies are the second most popular place for people to get a flu vaccination (18.4%), outnumbered only by a doctor’s surgery (39.8%). Comparably, in Australia the majority of respondents to a recent survey by Priceline Pharmacy said that they received a flu vaccination either from their GP (74%) or at work (21%).

You need to log in to read the rest of this article. Click here for details

Nominations for two pharmacist councillors for the Australian Pharmacy Council : 30/04/2012 :

The Australian Pharmacy Council (APC) is seeking applications from pharmacists for two vacant Councillor positions.

Applications must address the attributes noted below and include curriculum vitae.

Applications must reach the APC Office no later than Wednesday 16 May 2012.

You need to log in to read the rest of this article. Click here for details

August PBS price disclosure price cuts announced : 30/04/2012 :

The Department of Health and Ageing last week released details of the August 1 round of PBS price reductions that will occur as part of the ongoing price disclosure system agreed between Medicines Australia and the Government.

The 13 medicines set to take price cuts from August 1 are: Amisulpride (18.27%); Bisoprolol (18.75%); Cefalotin (16.99%); Doxorubicin (32.97%); Escitalopram (36.76%); Levetiracetam (14.15%); Meloxicam (23.62%); Mitozantrone (18.25%); Ondansetron (77.25%); Oxaliplatin (51.76%); Oxybutinin (11.25%); Perindopril (11.59%) and Prochlorperazine (25.55%).

Details are here.

You need to log in to read the rest of this article. Click here for details

Industry welcomes consultation on next step to strengthen regulation of complementary medicines : 30/04/2012 :

The Australian Self-Medication Industry (ASMI), the industry body representing non-prescription consumer healthcare products, has welcomed steps by the Therapeutic Goods Administration (TGA) to strengthen the regulation of complementary medicines (CMs).
 
Last week, the TGA issued a draft discussion paper, Evidence required to support indications for listed medicines ( here), which outlines the nature of evidence required to support health claims made for CMs.

You need to be a "premium" subscriber to read the rest of this article. Click here for details

Latest Webstercare newsletter : 30/04/2012 :

Every second month our friends at Webstercare produce a newsletter that is distributed to all aged care homes throughout Australia.

They've kindly agreed to make it available to pharmacists too, through AusPharm.

You need to log in to read the rest of this article. Click here for details

Hospital admissions rise, particularly in public hospitals : 30/04/2012 :

According to a report released yesterday by the Australian Institute of Health and Welfare (AIHW), the number of hospital admissions in Australia continues to rise, particularly in public hospitals.

The report, Australian hospital statistics 2010–11, outlines the change in hospital admissions between 2009–10 and 2010–11.

You need to log in to read the rest of this article. Click here for details

PSA Intern Training Program - 2012 second intake now open : 30/04/2012 :

The second intake of the Pharmaceutical Society of Australia’s (PSA) National Intern Training Program (NITP) is now open.
 
The PSA NITP is a high-quality, practically focused program designed to embed the knowledge and skills required to equip students for their working career after years of study. 

You need to log in to read the rest of this article. Click here for details

RGH E-Bulletin: Dabigatran – bleeding risk and renal function : 30/04/2012 :

The topic of this week's RGH E‑Bulletin is Dabigatran – bleeding risk and renal function.

"The oral anticoagulant dabigatran (Pradaxa®) is a direct thrombin inhibitor approved in Australia for the prevention of venous thromboembolism after major orthopaedic surgery, and for stroke prophylaxis in patients with atrial fibrillation (AF). Dabigatran is primarily renally cleared.  Reduced renal clearance increases drug exposure and the elimination half-life, which can cause an exaggerated anticoagulant effect. There is no antidote or reversal agent for dabigatran induced bleeding, however the drug is dialyzable, meaning that this approach can be considered in severe cases."

Click here to read the bulletin in full. The E‑Bulletins are archived on the AusPharmList website here.

You need to log in to read the rest of this article. Click here for details

PHARMeFOOTY weekly wrap : 27/04/2012 :

AFL Round 4

Round 4 of the 2012 AFL season saw Fremantle defeat St Kilda at Etihad Stadium on Friday night by 13 points, a great win for Coach Ross Lyon against his old club. Other highlights of the round included Essendon having a 30 point win over a flat Carlton side, the Magpies overpowering Port Adelaide by 4 goals and the Eagles getting over the line to defeat the Hawks by 5 points in an intense, hard and low scoring match.

Due to the ‘Representative Weekend’ there was no NRL Round.

You need to log in to read the rest of this article. Click here for details

APLF endorses Vision, aims to progress pharmacist prescribing : 27/04/2012 :

At its recent meeting, the Australian Pharmacy Liaison Forum (APLF) confirmed its support for the Vision for Pharmacists’ Practice in Australia document that was developed in 2011 following wide consultation with the profession (current version available here).

Forum members agreed that it is now timely for the profession to take ownership of the project and a map a way forward. The Forum says it will consider the functions and enablers necessary to realize the Vision at its coming meetings throughout the year.

You need to log in to read the rest of this article. Click here for details

NPS board chair Dr Janette Randall address to the National Press Club : 27/04/2012 :

NPS Board Chair Dr Janette Randall yesterday called on the government to take the lead on a cross sectoral approach towards tackling the antibiotic-resistance crisis facing the Australian community.

In an address to the National Press Club in Canberra, Dr Randall said the issue of antibiotic resistance is not restricted to the health sector with veterinary, agriculture and manufacturing all having their part to play.

You need to log in to read the rest of this article. Click here for details

Ranbaxy: look to India : 27/04/2012 :

Responding to this week's prediction from Alphapharm’s Medical Director, Greg Pearce, that PBS reforms may reduce generic manufacturers’ ability to offer discounts, Ranbaxy Australia's Managing Director, Alex Evans, said that manufacturers that continue with uncompetitive manufacturing bases, high fixed cost overheads and expensive sales and marketing infrastructures would indeed become non-viable.

"Our low manufacturing cost base and our local purpose designed, centralised, account management infrastructure means that we are well placed to offer the best prices now and in the future. We will continue to support our customers with great pricing and service, long after it is no longer viable for many other generic organisations.”

You need to log in to read the rest of this article. Click here for details

Pfizer Direct 'frequently' compromises patient care : 27/04/2012 :

This week's AusPharm online poll asked 'listers whether Pfizer Direct’s delivery policies and performance has resulted in adverse patient outcomes.

Just over half of all respondents (n=178) told us that this happened frequently with another 31% saying that the direct supply model compromised patient care 'occasionally'.

You need to log in to read the rest of this article. Click here for details

Pharmacy loses another product to grocery : 27/04/2012 :

The Advisory Committee on Medicines Scheduling (ACMS) yesterday released the (interim) decisions from its February 2012 meeting, among them a decision to exempt oral preparations containing 10 mg or less of loratadine in packs containing not more than 5 dosage units for the treatment of seasonal allergic rhinitis.

The down-scheduling is set to occur by September 2012.

You need to log in to read the rest of this article. Click here for details

PBS costs remain contained : 26/04/2012 :

PBS figures for March 2012, released by Medicare yesterday, show that costs remain contained.

In March 2012 17.0 million PBS/RPBS scripts with a government reimbursement value of $739 million were dispensed across the country. This represents a decline of 4% on the 2011 figures of 17.72 million items and a small increase in the 2011 dollar spend of $736 million.

The graph below depicts actual dollars, un-adjusted for CPI increases.

You need to be a "premium" subscriber to read the rest of this article. Click here for details

CPI rise in pharmaceuticals due to PBS safety net : 26/04/2012 :

Always quick to look after the interests of its members, peak pharma group Medicines Australia highlighted on Tuesday that the apparent surge in pharmaceutical prices included in Tuesday’s CPI figures for the March quarter are a consequence of the mechanics of the PBS safety net.

“The CPI pharmaceutical price should be considered in the context of the December 2011 CPI, when pharmaceutical prices fell 6% per cent,” said Medicines Australia chief executive Dr Brendan Shaw.

You need to log in to read the rest of this article. Click here for details

NPS urges consumers to sign up to be an antibiotic resistance fighter : 26/04/2012 :

NPS has launched a new Facebook page for Australians to sign up and become antibiotic resistance fighters at www.facebook.com/NPSmedicinewise
 
Created as part of a new campaign to tackle antibiotic resistance in the community, NPS is asking Australians to pledge to take three simple steps to combat the development and spread of this global problem. If 35,000 people sign up, Australians could significantly reduce antibiotic resistant bacteria.

You need to log in to read the rest of this article. Click here for details

Poll: Pfizer direct: how are they going? : 26/04/2012 :

There have been a number of posts to AusPharmList in recent days bucketing the performance of Pfizer Direct in getting Pfizer's products to pharmacies in a time frame that meets the needs of patients.

How has their performance been in your pharmacy? Please let us know by tickling the relevant box in today's AusPharm online poll.

Please note this poll will only run for 24 hours instead of the usual 48 (we'll publish the result tomorrow) so get your vote in now.

You need to log in to read the rest of this article. Click here for details

Pfizer direct: how are they going? : 25/04/2012 :

There have been a number of posts to AusPharmList in recent days bucketing the performance of Pfizer Direct in getting Pfizer's products to pharmacies in a time frame that meets the needs of patients.

How has their performance been in your pharmacy? Please let us know by tickling the relevant box in today's AusPharm online poll.

Please note this poll will only run for 24 hours instead of the usual 48 (we'll publish the result tomorrow) so get your vote in now.

You need to log in to read the rest of this article. Click here for details

Click here to go to the old "Industry News" page (pre 01/09/2006).